The antiparasitic drugs market is driven by factors such as the increasing prevalence of parasitic infections, rising demand for effective treatments, and advancements in drug development technologies. The market is also influenced by factors such as increasing awareness about parasitic infections, the growing demand for animal healthcare products, and the increasing investment in research and development activities. The availability of various government initiatives and favorable regulations is also driving the growth of the antiparasitic drugs market. However, the market is hindered by factors such as the high cost of drugs and the emergence of drug-resistant parasites. Nevertheless, the increasing focus on the development of novel drugs and the growing adoption of combination therapies are expected to create new opportunities for the growth of the antiparasitic drugs market.
Antiparasitic Drugs Market is estimated to be valued at US$ 22.22 Billion in 2022 and is expected to exhibit a CAGR of 5.6 % over the forecast period (2022-2030).
Key Competitors in the Antiparasitic Drugs Industry:
1. Merck KGaA
Merck KGaA is a German multinational pharmaceutical, chemical, and Life Sciences Company founded in 1668. The company is headquartered in Darmstadt, Germany and operates in over 70 countries worldwide. In March, 2023 Merck, a leading science and technology company, and Intel Corporation, one of the world’s largest semiconductor designers and manufacturers, are enabling more sustainable semiconductor manufacturing solutions by funding a new academic research program in Europe.
2. GlaxoSmithKline plc
GlaxoSmithKline plc is a British multinational pharmaceutical company founded in 2000. The company's headquarters is located in Brentford, London, United Kingdom, and it operates in over 150 countries worldwide. In March, 2023 GSK plc and SCYNEXIS, Inc. announced they have entered into an exclusive licence agreement for Brexafemme (ibrexafungerp tablets), a US FDA approved, first-in-class antifungal for the treatment of vulvovaginal candidiasis (VVC) and for reduction in the incidence of recurrent VVC (RVVC).
3. Dr. Reddy’s Laboratories Ltd
Dr. Reddy's Laboratories Ltd is an Indian multinational pharmaceutical company founded in 1984. The company's headquarters is located in Hyderabad, Telangana, India, and it operates in over 20 countries worldwide. In February, 2023 Dr. Reddy’s announced that it has entered into a definitive agreement to acquire the U.S. generic prescription product portfolio of Salisbury, Australia, based Mayne Pharma Group Limited
4. Cipla Limited
Cipla Limited is an Indian multinational pharmaceutical company founded in 1935. The company's headquarters is located in Mumbai, Maharashtra, India, and it operates in over 80 countries worldwide.
5. Cadila Pharmaceuticals
Cadila Pharmaceuticals is an Indian multinational pharmaceutical company founded in 1951. The company's headquarters is located in Ahmedabad, Gujarat, India, and it operates in over 50 countries worldwide. In July, 2022 Cipla Limited announced that Cipla Health Limited (CHL), wholly owned subsidiary and consumer healthcare arm of the Company has signed definitive agreements for acquisition of Endura Mass, a renowned nutritional supplement brand in the category of weight gain from Medinnbelle Herbalcare Private Limited.
6. Watson International Limited
Watson International Limited is a Hong Kong-based pharmaceutical company founded in 1993. The company operates in over 60 countries worldwide.
7. Vivaldis
Vivaldis is a Belgian multinational pharmaceutical company founded in 1999. The company's headquarters is located in Vilvoorde, Belgium, and it operates in over 50 countries worldwide.
8. Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company founded in 1977. The company's headquarters is located in Mumbai, Maharashtra, India, and it operates in over 80 countries worldwide.
9. Viatris Inc.
Viatris Inc. is an American multinational pharmaceutical company founded in 1961. The company's headquarters is located in Pittsburgh, Pennsylvania, United States, and it operates in over 165 countries worldwide.
10. Novartis AG
Novartis AG is a Swiss multinational pharmaceutical company founded in 1996. The company's headquarters is located in Basel, Switzerland, and it operates in over 155 countries worldwide. In March, 2023 Sandoz, the global leader in off-patent medicines, has signed an agreement to acquire worldwide product rights for leading systemic antifungal agent Mycamine® (micafungin sodium, Funguard® in Japan) from Astellas.
11. AdvaCare Pharma
AdvaCare Pharma is a multinational pharmaceutical company founded in 2005. The company's headquarters is located in Ningbo, China, and it operates in over 50 countries worldwide.
12. Lupin
Lupin is an Indian multinational pharmaceutical company founded in 1968. The company's headquarters is located in Mumbai, Maharashtra, India, and it operates in over 100 countries worldwide.
13. Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. is an Indian multinational pharmaceutical company founded in 1983. The company's headquarters is located in Mumbai, Maharashtra, India, and it operates in over 100 countries worldwide.
14. Aurobindo Pharma
Aurobindo Pharma is an Indian multinational pharmaceutical company founded in 1986. The company's headquarters is located in Hyderabad, Telangana, India, and it operates in over 150 countries worldwide.
*Definition- Antiparasitic drugs are medications used to treat parasitic infections caused by organisms such as protozoa, helminths, and ectoparasites. These drugs work by targeting the parasite and either killing it or inhibiting its growth and reproduction within the host.
